The global oligonucleotide active pharmaceutical ingredients (API) market is poised for significant growth, with demand expected to increase at a CAGR of 5.60% from 2024 to 2034. The market, valued at USD 2.81 billion in 2024, is projected to reach USD 4.84 billion by the end of the forecast period. This growth is largely driven …
Tag Archives: Oligonucleotide API Market
Oligonucleotide API Market Projected to Reach USD 4.84 Billion by 2034 at a 5.60% of CAGR
The global oligonucleotide API market is poised for substantial growth, driven by increasing demand for new drug classes. According to recent projections, the market is expected to rise at a robust compound annual growth rate (CAGR) of 5.60% from 2024 to 2034. The market, valued at approximately USD 2.81 billion in 2024, is forecasted to expand to USD 4.84 billion by the end …
Oligonucleotide API Market Set for Steady Growth at 5.6% CAGR, Reaching US$4.84 Billion by 2034 | FMI Study
The Oligonucleotide API Market is on track for a promising future, fueled by the increasing demand for innovative drug therapies. According to a recent market analysis, the market is currently valued at US$2.81 billion in 2024. This positive trend is expected to continue, with a projected Compound Annual Growth Rate (CAGR) of 5.60% over the …
Global Oligonucleotide API Industry Poised for Steady Growth, Reaching US$4.84 Billion by 2034, Fueled by Demand for New Drug Therapies
The Global Oligonucleotide API Industry is poised for significant expansion, driven by the rising demand for novel drug classes. According to a recent market analysis, the market, currently valued at US$2.81 billion in 2024, is expected to climb steadily at a Compound Annual Growth Rate (CAGR) of 5.60% over the next decade. This positive growth …
Global Oligonucleotide API Industry Eyes a Striking US$ 4.84 Billion Expansion, Riding the Wave of a 5.60% CAGR through 2034 | FMI
In response to the escalating demand for innovative drug classes, the Global Oligonucleotide API Industry is poised for a remarkable surge, with a projected high Compound Annual Growth Rate (CAGR) of 5.60% from 2024 to 2034. According to market analysts, this surge is expected to propel the global oligonucleotide API market from its 2024 valuation …
Global Oligonucleotide API Industry Poised for a Remarkable US$ 5.36 Billion Growth, Fueled by a Steady 10.2% CAGR till 2030 | FMI
The Global Oligonucleotide API Market is poised for substantial growth between 2022 and 2030, with a robust CAGR of 10.2%, primarily driven by the increasing demand for innovative drug classes. Consequently, it is projected that by the close of 2030, the global market for oligonucleotide Active Pharmaceutical Ingredients (APIs) will have surged from a valuation of US$ …
Global Oligonucleotide API Industry’s Remarkable CAGR of 10.2% Leading to a US$5.36 Billion Market in 2030 | FMI Reports
The Global Oligonucleotide (API) Industry is on the verge of a remarkable transformation, with a forecasted Compound Annual Growth Rate (CAGR) of 10.2% between 2022 and 2030. This substantial growth is fueled by the surging demand for innovative drug classes, making it one of the most promising sectors in the pharmaceutical industry. According to a …
Oligonucleotide APIs Market | A High-Growth Industry Projected to Reach US$ 5.36 Billion by 2030, at a CAGR of 10.2%
Because of the increased demand for novel drug classes, the Oligonucleotide APIs Market Demand is predicted to rise at a high CAGR of 10.2% between 2022 and 2030. As a result, the global oligonucleotide API market is predicted to rise from US$ 2.46 billion in 2022 to US$ 5.36 billion by 2030. According to FMI’s …
Oligonucleotide APIs Market is expected to reach a value of US$ 5.36 Billion by 2030, at a CAGR 10.2%
Demand for oligonucleotide APIs is expected to develop at a high CAGR of 10.2% between 2022 and 2030, owing to the growing need for novel medication classes. As a result, the global oligonucleotide API market is expected to grow from US$ 2.46 billion in 2022 to US$ 5.36 billion by the end of 2030. According …